Location History:
- Washington, DC (US) (2003)
- Goettingen, DE (2008)
Company Filing History:
Years Active: 2003-2008
Title: The Innovations of Heidi Eve Hahn
Introduction
Heidi Eve Hahn is a prominent inventor based in Goettingen, Germany. She has made significant contributions to the field of medical research, particularly in the area of cancer genetics. With a total of 2 patents, her work focuses on understanding and addressing the genetic factors that contribute to basal cell carcinoma.
Latest Patents
One of her latest patents is related to the basal cell carcinoma tumor suppressor protein. This invention provides for a tumor suppressor gene inactivation, which is a causal factor in nevoid basal cell carcinoma syndrome and various sporadic basal cell carcinomas. The NBCCS gene is a homologue of the patched (ptc) gene. Another patent she holds is also focused on the basal cell carcinoma tumor suppressor gene, reiterating the importance of this genetic research in combating cancer.
Career Highlights
Heidi Eve Hahn works for the United States of America, as represented by the Secretary, Department of Health and Human Services. Her role in this esteemed organization highlights her commitment to advancing health research and innovation.
Collaborations
Heidi has collaborated with notable colleagues, including Michael C. Dean and Carol Wicking. These partnerships have further enriched her research and contributed to her success in the field.
Conclusion
Heidi Eve Hahn's innovative work in cancer genetics exemplifies the critical role of research in understanding and treating diseases. Her patents reflect her dedication to improving health outcomes through scientific discovery.